Tens of thousands of people who have a stroke could be diagnosed and treated sooner as new data found that the average time between onset of first symptoms and a 999 call being made was nearly an hour ...

Thousands of patients could receive the all-clear for suspected throat cancer faster, thanks to a new iPhone device and app being piloted by the NHS. The innovative adapter providing a 32mm lens and ...

The NHS is now offering the public support in how to access online health services including the NHS App at 1,400 libraries across England. More than two in five public library services (64 out of 151 ...

Visits for prostate cancer symptoms advice on the NHS website rose by 672% following Sir Chris Hoy’s announcement about his terminal prognosis. New figures from NHS England show that in the 48 hours ...

How to become a supplier to the NHS We are transparent about how we spend public money and award contracts, so that it is fair to business, we secure the best outcomes for patients, and taxpayers can ...

We all know there are big challenges facing the NHS. Our staff are working harder than ever to get services back on track, to get waiting lists down and consistently deliver the best care. Yet too ...

The accountability report sets out how NHS England meets key accountability requirements to Parliament and is comprised of three key sections: The corporate governance report sets out how the ...

Hertfordshire Partnership University NHS Foundation Trust (HPFT) supports people with mental ill health, learning disabilities and autism across Hertfordshire, Buckinghamshire, Norfolk and Waveney and ...

The Newcastle upon Tyne Hospitals NHS Foundation Trust seeks a Non-Executive Director with social care/community services/health inequalities expertise and an Associate Non-Executive Director with ...

The NHS trust voted the best to work for anywhere in the Midlands by its own staff is looking to appoint two Non-Executive Directors and one Associate Non-Executive Director to help continue to lead ...

NHS England has confirmed that peginterferon alfa-2a and ropeginterferon alfa-2b will be made available as treatment options for people with myeloproliferative neoplasms (MPNs) within the criteria set ...